MYOcardial ischemia detection by circulating bioMARKERs: * the MYOMARKER-study*

MYOcardial ischemia detection by circulating bioMARKERs: * the MYOMARKER-study* - MYOMARKER

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40975

Enrollment

1265

Registered

2014-06-26

Start date

2014-08-12

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angina (pectoris) ischemic coronary artery disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients (age >18yr), who are being evaluated in the Meander Medical Center cardiology outpatient clinic with symptoms suggestive for ischemic coronary artery disease, and who will undergo radionuclide myocardial perfusion imaging (rMPI) as indicated by their own cardiologist.

Exclusion criteria

Exclusion criteria: - Age

Design outcomes

Primary

Measure	Time frame
Parameter; Extracellular vesicle protein- and miRNA-concentration, and gene expression profiles in circulating cells. Endpoint: Objectified ischemic coronary artery disease, determined by radionuclide myocardial perfusion imaging (Rubidium-82).	—

Secondary

Measure	Time frame
Follow-up: all-cause mortality, cardiovascular death, non-fatal MI, coronary revascularisation, stroke, and peripheral vascular interventions.	—

Countries

Netherlands

Outcome results